Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
Zancan M, Galdi F, Di Tonno F, Mazzariol C, Orlando C, Malentacchi F, Agostini M, Maran M, Del Bianco P, Fabricio AS, Murer B, Pianon C, Gion M. Zancan M, et al. Int J Biol Markers. 2009 Jul-Sep;24(3):147-55. doi: 10.1177/172460080902400304. Int J Biol Markers. 2009. PMID: 19787625 Free article.
Free DNA in urine: a new marker for bladder cancer? Preliminary data.
Zancan M, Franceschini R, Mimmo C, Vianello M, Di Tonno F, Mazzariol C, Malossini G, Gion M. Zancan M, et al. Int J Biol Markers. 2005 Apr-Jun;20(2):134-6. doi: 10.1177/172460080502000209. Int J Biol Markers. 2005. PMID: 16011045 Free article.
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
Paradiso A, Mangia A, Orlando C, Verderio P, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Romani M, Belloni E, Cavallo D, Ulivi P, Tommasi S, Steffan A, Russo A, Alessio M, Calistri D, Zancan M, Parrela P, Broggini M, Giuseppe A, Buttitta F, Finocchiaro G, Mazzocco K, Veronesi G, Landuzzi L, Benevolo M, Mariani L, De Marco F, Venuti A, Giannelli G, Quaranta M, Trojano V. Paradiso A, et al. Among authors: zancan m. Int J Biol Markers. 2009 Jul-Sep;24(3):119-29. doi: 10.1177/172460080902400301. Int J Biol Markers. 2009. PMID: 19787622 Free article.
Testosterone and biological characteristics of breast cancers in postmenopausal women.
Secreto G, Venturelli E, Meneghini E, Greco M, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A. Secreto G, et al. Among authors: zancan m. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2942-8. doi: 10.1158/1055-9965.EPI-09-0540. Epub 2009 Oct 20. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19843675
Shed HER2 surrogacy evaluation in primary breast cancer patients: a study assessing tumor tissue HER2 expression at both extracellular and intracellular levels.
Fabricio ASC, Michilin S, Zancan M, Agnolon V, Peloso L, Dittadi R, Scapinello A, Ceccarelli C, Gion M. Fabricio ASC, et al. Among authors: zancan m. Scand J Clin Lab Invest. 2019 Jul;79(4):260-267. doi: 10.1080/00365513.2019.1600200. Epub 2019 Apr 15. Scand J Clin Lab Invest. 2019. PMID: 30982358
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer.
Gasparini G, Gion M, Mariani L, Papaldo P, Crivellari D, Filippelli G, Morabito A, Silingardi V, Torino F, Spada A, Zancan M, De Sio L, Caputo A, Cognetti F, Lambiase A, Amadori D. Gasparini G, et al. Among authors: zancan m. Breast Cancer Res Treat. 2007 Mar;101(3):355-65. doi: 10.1007/s10549-006-9306-9. Epub 2006 Jul 19. Breast Cancer Res Treat. 2007. PMID: 16850247 Clinical Trial.
25 results